News

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
CET - Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31 December ...
WINFARM: Ongoing sales momentum in Q1 2025 with +7.9% growth.
PRESS RELEASE Loudéac, April 29, 2025 Ongoing sales momentum in Q1 2025 with +7.9% growth 2025 Outlook: maintained strong sales momentum and expected improvement in results WINFARM (ISIN: FR0014000P11 ...